(NASDAQ: IRTC) Irhythm Holdings's forecast annual revenue growth rate of 13.6% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.03%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.15%.
Irhythm Holdings's revenue in 2026 is $854,044,000.On average, 18 Wall Street analysts forecast IRTC's revenue for 2026 to be $30,618,398,832, with the lowest IRTC revenue forecast at $29,321,746,941, and the highest IRTC revenue forecast at $31,620,891,946. On average, 18 Wall Street analysts forecast IRTC's revenue for 2027 to be $36,711,015,432, with the lowest IRTC revenue forecast at $33,920,709,314, and the highest IRTC revenue forecast at $38,122,977,564.
In 2028, IRTC is forecast to generate $41,921,828,062 in revenue, with the lowest revenue forecast at $38,694,486,046 and the highest revenue forecast at $44,947,461,202.